Methods of using macrocyclic modulators of the ghrelin receptor

Details for Australian Patent Application No. 2005264907 (hide)

International Classifications

Event Publications

8 February 2007 PCT application entered the National Phase

PCT publication WO2006/009645 Priority application(s): WO2006/009645

15 February 2007 Amendment Made

The nature of the amendment is: Add priority details 11/149,731 10 Jun 2005 US 2005267286 Shape Corporation The nature of the amendment is as shown in the statement(s) filed 08 Jan 2007

4 October 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 16 Jan 2007

17 December 2009 Amendment Made

The nature of the amendment is: Amend the priority details from US 60/622,055 27 October 2004 to US 60/622,005 27 October 2004 2006

29 September 2011 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Tranzyme Pharma, Inc., Application No. 2005264907, under INID (31) add 11/149,731, under INID add 10.06.2005 and under INID add US

27 October 2011 Alteration of Name

The name of the applicant has been altered to Tranzyme Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.